Proposed mechanism for the actions of HO-1 in vivo. HO-1 activation by VEGF favors endothelial cell proliferation while inhibiting leukocyte migration and activity, thus resulting in a predominantly noninflammatory angiogenesis. However, when HO-1 is inhibited, there is increased leukocyte migration with subsequent local release of growth factors and induction of inflammatory angiogenesis.